Top Banner
Bio-Pharma Entrepreneur, Jay Goth’s insights for Family offices and start-ups

Bio-Pharma Entrepreneur, Jay Goth’s insights for Family offices and start-ups

The interest in bio-pharma and health-tech is at high levels. Key investors are coming good with their commitment to nurture bio-pharma, health-tech ideas and research.

PeachCap. Disrupting the outsourced Family Office concept.

PeachCap. Disrupting the outsourced Family Office concept.

So you don’t have a billion dollars. But you do need a family office for that $100-150 million wealth-chest you have. Problem is that a family office comes with a steep tag. You need a CEO, CIO, CTO, admin, analysts, operations and of course the tax and legal people, all with a fully-equipped office for them.

Novolyze. Funding for germs

There is a need today for family offices to also look at small but niche investments that are in businesses that serve core and longterm human needs. The recent Novolyze raise of €2.2m had a couple of family offices as part of the investment group. The France-based Novolyze is in the very niche segment of producing surrogate micro-organisms which are then used for testing processes by the food industry to make sure that their products are infection free. For most people food infection is just half a day of han...

Family offices. Perfect prescription for bio-pharma start-ups.

Family offices. Perfect prescription for bio-pharma start-ups.

Gene modulation, block-chain technology for research, body integrated artificial intelligence, organ printing are buzz words that have come out of the realm of science fiction into the zone of the doable. The investments needed are huge but the returns can be simply sky-high.

Family Offices Invest in Healthcare and Medical Development

Among other non-traditional investments, the family office sector is displaying a keen interest in the healthcare and life science space. The foundation of these investments lies in the need for diversification, which is being addressed through higher connectivity and increased accessibility. Compounding this advantage is the philanthropic nature of the investment. Dallas-based Green Park & Golf Ventures, a family office with a concentration on health and medical sectors has raised a portion of its...

Bonus Section: Precision Medicine

Bonus Section: Precision Medicine

When you look at what is affecting health in emerging markets, there are many areas of need. Naturally cancer is a global problem, but underlying conditions like inflammation, nutrition and lifestyle choices are also areas that need focus and attention. One of the great things about precision medicine is that we can now include many different factors, including biological and phenotypic, into our diagnostic and prognostic models. Let’s treat the causes, not the symptoms.

Right Banner 2Right Banner 1